Khiron, a Colombian company, will enter the market with medicinal cannabis

In the medium term, Khiron seeks to reach more than 68 million patients in Latin America, who could benefit from the prescription of medicinal cannabis. After obtaining the full licenses to cultivate, produce and distribute cannabis for medicinal use, Khiron Colombia SAS, a subsidiary of Canad... ...

Read More

In six months Khiron Colombia will enter the market with medicinal cannabis

After obtaining the full licenses to cultivate, produce and distribute cannabis for medicinal use, Khiron Colombia SAS, a subsidiary of Canadian Khiron Life Sciences Corp, is preparing to meet the needs of 5 million patients in Colombia with diverse medical conditions such as epilepsy, multiple s... ...

Read More